Reference number : 033-2020-2021-Q4-513419, amendment number : , agreement type : C, recipient legal name : Immune Biosolutions Inc., recipient country : CA, recipient province : QC, recipient city : Sherbrooke, recipient postal code : J1E0M8, program name english : SIF Stream 1- R&D, program name french : FIS Volet 1- R&D, program purpose english : -Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector., program purpose french : -favoriser les activités de R-D qui accéléreront le transfert de la technologie et la commercialisation de produits, de processus et de services novateurs ;-faciliter la croissance et l'expansion des entreprises au Canada ;-attirer et conserver des investissements de grande envergure au Canada ; et-faire progresser la recherche industrielle, le développement et la démonstration de technologies grâce à la collaboration entre les universitaires, les organisations à but non lucratif et le secteur privé., agreement title english : IBio COVID-19 Therapy Project, agreement title french : Projet de thérapie IBio COVID-19, agreement number : 513419, agreement value : 13442000.0, agreement start date : 2020-04-29, agreement end date : 2023-09-30, description english : Immune Biosolutions inc. will develop a medical counter measure (MCM) and contribute to Canada's ability to secure an effective therapeutic in response to COVID-19., description french : Immune Biosolutions inc. développera une contre-mesure médicale et contribuera à  la capacité du Canada à  obtenir un traitement efficace en réponse à  la COVID-19., expected results english : It is expected that this project will strengthen Canada's response to COVID-19, as well as diversify Canada's medical counter measures portfolio to improve the health and safety of Canadians. This project will create 6 new full-tim jobs and maintain 19 full-time jobs within Canada, expected results french : On s'attend à  ce que ce projet renforce la réponse du Canada à  la COVID-19, ainsi que la diversification du portefeuille de contre-mesures médicales du Canada afin d'améliorer la santé et la sécurité des Canadiens. Ce projet permettra de créer 6 nouveaux emplois à  temps plein et de maintenir 19 emplois à  temps plein au Canada., additional information english : This is a non-repayable contribution, additional information french : Il s'agit d'une contribution partiellement remboursable, owner organization : ic, owner organization title : Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada